MENÚ
AR | ARS
AR | ARS
-
- Todas las centrífugas
- Centrífugas de sobremesa
- Centrífugas de suelo
- Centrífugas refrigeradas
- Microcentrífugas
- Centrífugas multipropósito
- Centrífugas de alta velocidad
- Ultracentrífugas
- Concentrador
- Consumibles para ultracentrífugas y centrífugas de alta velocidad
- Tubos de centrífuga
- Placas de centrífuga
- Gestión de muestras e información
-
- Todas las pipetas, dispensadores y manipuladores de líquidos automatizados
- Pipetas mecánicas
- Pipetas electrónicas
- Pipetas multicanal
- Pipetas y dispensadores de desplazamiento positivo
- Puntas de pipeta
- Dispensadores de botella
- Controladores de pipetas
- Accesorios para dispensadores y pipetas
- Pipeteo automatizado
- Consumibles para automatización
- Accesorios de automatización
- Servicios de manipulación de líquidos y pipetas
Sorry, we couldn't find anything on our website containing your search term.
Está a punto de abandonar este sitio.
Por favor, tenga en cuenta que su carro de la compra actual no ha sido guardado todavía y no podrá ser restablecido en el nuevo sitio ni cuando regrese. Si desea guardar su carro de la compra, inicie sesión en su cuenta.
Sorry, we couldn't find anything on our website containing your search term.
Vaccine Research Discovered
Well thought-out tools for pharmaceutical and biotech laboratories
Read more
Read less
THE MOST NOVEL VACCINES
Nucleic acid vaccines
Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding viral antigenic components to express specific proteins of a pathogen after injection. The technology of mRNA vaccines made its breakthrough with SARS-CoV-2. With dozens of new applications including HIV, cancer, shingles, flu, cardiovascular applications, or Zika, it is a very promising technology.
Nucleic acid vaccines are made up of mRNA or plasmid DNA encoding viral antigenic components to express specific proteins of a pathogen after injection. The technology of mRNA vaccines made its breakthrough with SARS-CoV-2. With dozens of new applications including HIV, cancer, shingles, flu, cardiovascular applications, or Zika, it is a very promising technology.
Leer más
➕ Multiple advantages such as exceptionally fast modifiability in response to mutations, high versatility, high safety, and a fast, cost-efficient, and scalable production in a cell-free system. Vaccines for multiple indications can be produced using the same process.
➖ During vaccination the mRNA must be delivered directly into cells, which requires specific injection devices, electroporation, or a carrier molecule. mRNA vaccines exhibit instability and require a cold chain
➖ During vaccination the mRNA must be delivered directly into cells, which requires specific injection devices, electroporation, or a carrier molecule. mRNA vaccines exhibit instability and require a cold chain
Leer más
BETTER MRNA VACCINE DEVELOPMENT
Leer más
*All products are for Research Use Only (RUO).
Leer más
Leer más